3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
100
Glioma
42
Brain Neoplasms
28
Neuroblastoma
25
Astrocytoma
18
Gliosarcoma
15
Sarcoma, Ewing
12
Rhabdomyosarcoma
12
Neoplasms
12
Recurrence
11
Medulloblastoma
11
Small Cell Lung Carcinoma
8
Sarcoma
8
Oligodendroglioma
8
Melanoma
7
Osteosarcoma
6
Ependymoma
6
Diffuse Intrinsic Pontine Glioma
6
Central Nervous System Neoplasms
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Desmoplastic Small Round Cell Tumor
3
Colorectal Neoplasms
3
Interventions
Capecitabine
41
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
21
Cetuximab
14
Bevacizumab
14
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Surgical Procedures, Operative
8
Folfox protocol
8
Drug Therapy
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Temozolomide
×
1 year
×
Clear all
No trials found.